Dr. Reddy's Laboratories Ltd. closed 18.57% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

India's Dr Reddy's Laboratories, one of country's largest generic drugmakers, said that it is open to expanding its manufacturing footprint in the key U.S. market as tariff threat looms. "We are more ...

Hyderabad: Dr Reddy's Laboratories posted a consolidated 22% jump in profit after tax attributable to equity holders at Rs ...

Dr. Reddy's Laboratories announced a 21% surge in net profit, reaching Rs 1,587 crore for the March 2025 quarter, fueled by ...

Dr Reddy's Laboratories reported a 22% year-on-year increase in Q4FY25 consolidated net profit to ₹1,594 crore, surpassing ...

For the quarter, EBITDA jumped 58.9% to ₹2,975 crore, while margin expanded by 510 basis points from last year to 29.1%.

Markets top brokerage firms forecast suggest that Dr Reddys Laboratories will report a net profit of approximately Rs 1,456.5 ...

HYDERABAD, India — HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. (RDY) on Friday reported net income of $187 million in its fiscal fourth quarter. The Hyderabad, India-based company said it had net ...

Important names like Dr Reddy's Laboratories, Manappuram Finance, Swiggy, CE Info Systems, Bank of India, India Shelter ...

CEO Erez Israeli has projected double-digit growth for FY26, primarily on the back of semaglutide launches and pipeline ...

Dr Reddy's Laboratories recorded a 21% increase in net profit for the March quarter, reaching Rs 1,587 crore, supported by ...

Dr Reddy's posted consolidated net profit growth of 21 per cent year-on-year to Rs 1,587 crore during the March quarter, ...